End TB Clin.Trial Output 2

Filter
A1: Web of Science-article

Search results

  • 2021

    Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

    Guglielmetti, L., Ardizzoni, E., Atger, M., Baudin, E., Berikova, E., Bonnet, M., Chang, E., Cloez, S., Coit, J. M., Cox, J., de Jong, B. C., Delifer, C., Do, J. M., Tozzi, D. D. S., Ducher, Ferlazzo, G., Gouillou, M., Khan, A., Khan, U., Lachenal, N., & 24 othersLaHood, A. N., Lecca, L., Mazmanian, M., McIlleron, H., Moschioni, M., O'Brien, K., Okunbor, O., Oyewusi, L., Panda, S., Patil, S. B., Phillips, P. P. J., Pichon, L., Rupasinghe, P., Rich, M. L., Saluhuddin, N., Seung, K. J., Tamirat, M., Trippa, L., Cellamare, M., Velasquez, G. E., Wasserman, S., Zimetbaum, P. J., Varaine, F. & Mitnick, C. D., 2021, In: Trials. 22, 1, 15 p., 651.

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Open Access
    File
    92 Downloads (Pure)